Development and validation of an optimized prediction of mortality for candidates awaiting liver transplantation

被引:84
作者
Bertsimas, Dimitris [1 ]
Kung, Jerry [1 ]
Trichakis, Nikolaos [1 ]
Wang, Yuchen [1 ]
Hirose, Ryutaro [2 ]
Vagefi, Parsia A. [3 ]
机构
[1] MIT, Operat Res Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA
[2] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA
[3] Univ Texas Southwestern Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA
关键词
ethics and public policy; liver transplantation; hepatology; auxiliary; simulation; statistics; HEPATOCELLULAR-CARCINOMA; MELD; ALLOCATION; DELTA; MODEL;
D O I
10.1111/ajt.15172
中图分类号
R61 [外科手术学];
学科分类号
摘要
Since 2002, the Model for End-Stage Liver Disease (MELD) has been used to rank liver transplant candidates. However, despite numerous revisions, MELD allocation still does not allow for equitable access to all waitlisted candidates. An optimized prediction of mortality (OPOM) was developed () utilizing machine-learning optimal classification tree models trained to predict a candidate's 3-month waitlist mortality or removal utilizing the Standard Transplant Analysis and Research (STAR) dataset. The Liver Simulated Allocation Model (LSAM) was then used to compare OPOM to MELD-based allocation. Out-of-sample area under the curve (AUC) was also calculated for candidate groups of increasing disease severity. OPOM allocation, when compared to MELD, reduced mortality on average by 417.96 (406.8-428.4) deaths every year in LSAM analysis. Improved survival was noted across all candidate demographics, diagnoses, and geographic regions. OPOM delivered a substantially higher AUC across all disease severity groups. OPOM more accurately and objectively prioritizes candidates for liver transplantation based on disease severity, allowing for more equitable allocation of livers with a resultant significant number of additional lives saved every year. These data demonstrate the potential of machine learning technology to help guide clinical practice, and potentially guide national policy.
引用
收藏
页码:1109 / 1118
页数:10
相关论文
共 50 条
  • [1] Serum Ferritin Concentration Predicts Mortality in Patients Awaiting Liver Transplantation
    Walker, Nicole M.
    Stuart, Katherine A.
    Ryan, Rebecca J.
    Desai, Shireena
    Saab, Sammy
    Nicol, Jennifer A.
    Fletcher, Linda M.
    Crawford, Darrell H. G.
    HEPATOLOGY, 2010, 51 (05) : 1683 - 1691
  • [2] A Revised Model for End-Stage Liver Disease Optimizes Prediction of Mortality Among Patients Awaiting Liver Transplantation
    Leise, Michael D.
    Kim, W. Ray
    Kremers, Walter K.
    Larson, Joseph J.
    Benson, Joanne T.
    Therneau, Terry M.
    GASTROENTEROLOGY, 2011, 140 (07) : 1952 - 1960
  • [3] Including body composition in MELD scores improves mortality prediction among patients awaiting liver transplantation
    Hamaguchi, Yuhei
    Kaido, Toshimi
    Okumura, Shinya
    Kobayashi, Atsushi
    Shirai, Hisaya
    Yao, Siyuan
    Yagi, Shintaro
    Kamo, Naoko
    Uemoto, Shinji
    CLINICAL NUTRITION, 2020, 39 (06) : 1885 - 1892
  • [4] Downstaging Techniques for Hepatocellular Carcinoma in Candidates Awaiting Liver Transplantation
    Matevish, Lauren
    Patel, Madhukar S.
    Vagefi, Parsia A.
    SURGICAL CLINICS OF NORTH AMERICA, 2024, 104 (01) : 145 - 162
  • [5] Clinician assessments of health status predict mortality in patients with end-stage liver disease awaiting liver transplantation
    Lai, Jennifer C.
    Covinsky, Kenneth E.
    Hayssen, Hilary
    Lizaola, Blanca
    Dodge, Jennifer L.
    Roberts, John P.
    Terrault, Norah A.
    Feng, Sandy
    LIVER INTERNATIONAL, 2015, 35 (09) : 2167 - 2173
  • [6] Can the Dropout Risk of Candidates with Hepatocellular Carcinoma Predict Survival after Liver Transplantation?
    Cucchetti, A.
    Cescon, M.
    Bertuzzo, V.
    Bigonzi, E.
    Ercolani, G.
    Morelli, M. C.
    Ravaioli, M.
    Pinna, A. D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 (08) : 1696 - 1704
  • [7] Liver transplantation and waitlist mortality for HCC and non-HCC candidates following the 2015 HCC exception policy change
    Ishaque, Tanveen
    Massie, Allan B.
    Bowring, Mary G.
    Haugen, Christine E.
    Ruck, Jessica M.
    Halpern, Samantha E.
    Waldram, Madeleine M.
    Henderson, Macey L.
    Wang, Jacqueline M. Garonzik
    Cameron, Andrew M.
    Philosophe, Benjamin
    Ottmann, Shane
    Rositch, Anne F.
    Segev, Dorry L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 (02) : 564 - 572
  • [8] Prehabilitation in patients awaiting liver transplantation
    Benmassaoud, Amine
    Martel, Myriam
    Carli, Franco
    Geraci, Olivia
    Daskalopoulou, Stella S.
    Sebastiani, Giada
    Bessissow, Amal
    TRANSPLANTATION REVIEWS, 2024, 38 (02)
  • [9] Higher Mortality and Survival Benefit in Obese Patients Awaiting Liver Transplantation
    Schlansky, Barry
    Naugler, Willscott E.
    Orloff, Susan L.
    Enestvedt, C. Kristian
    TRANSPLANTATION, 2016, 100 (12) : 2648 - 2655
  • [10] Incidence and risk factors for mortality in patients with cirrhosis awaiting liver transplantation
    Jain, Mayank
    Varghese, Joy
    Kedarishetty, Chandan Kumar
    Srinivasan, Vijaya
    Venkataraman, Jayanthi
    INDIAN JOURNAL OF TRANSPLANTATION, 2019, 13 (03) : 210 - 215